Neurocrine Biosciences (NBIX) Interest & Investment Income (2009 - 2026)
Neurocrine Biosciences (NBIX) recorded Interest & Investment Income of $5 million in Q3 2026, down 77.5% from $22.2 million a year earlier and down 59.7% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Interest & Investment Income (2009 - 2026) Analysis & Trends
On a TTM basis, Neurocrine Biosciences' Interest & Investment Income came in at $71.3 million as of Sep 30, 2026, down 18.0% year-over-year; for FY2025, it was $90.3 million, down 0.8% from FY2024.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 48.3% (FY2020 to FY2025).
- Across earlier years, Interest & Investment Income came in at $91 million in FY2024 (+72.3%), $52.8 million in FY2023, $4.1 million in FY2022 (+7.9%) and $3.8 million in FY2021 (-69.8%).
- The Q3 2026 figure is the lowest quarterly Interest & Investment Income since Q4 2022.
- On a year-over-year basis, Interest & Investment Income rose in three of the last eight quarters, with an average decline of 8.9%.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 880.0% in Q1 2023, against a decline of 77.5% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.4 million (Q2 2026), $28.1 million (Q1 2026) and $25.8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 5.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.00 Mn |
| Jun 30, 2026 | 12.40 Mn |
| Mar 31, 2026 | 28.10 Mn |
| Dec 31, 2025 | 25.80 Mn |
| Sep 30, 2025 | 22.20 Mn |
| Jun 30, 2025 | 20.60 Mn |
| Mar 31, 2025 | 21.70 Mn |
| Dec 31, 2024 | 22.50 Mn |
| Sep 30, 2024 | 23.40 Mn |
| Jun 30, 2024 | 22.80 Mn |
| Mar 31, 2024 | 22.30 Mn |
| Dec 31, 2023 | 18.90 Mn |
| Sep 30, 2023 | 14.50 Mn |
| Jun 30, 2023 | 10.70 Mn |
| Mar 31, 2023 | 9.80 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 700,000.00 |
API Access
Neurocrine Biosciences Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();